Human element [ hs220 ]Position: chr7:114,070,779-114,073,266 (UCSC browser) Source: Lawrence Berkeley National Laboratory Flanking genes: FOXP2(intragenic) Timepoints: e11.5 This sequence did not show observable enhancer activities at E11.5 We define a negative enhancer at this developmental stage when at least 3 transgenics were obtained and yet no reproducible pattern of expression was observed. This does not mean that this sequence is not an enhancer at another time point or a weak enhancer at this time point but below the detectable range at our level of resolution. Fasta sequence CAgCTGTGAACATGTGCTCAGTCTTTTtgataacctagaaagaatgtttctctgatgcca atatttaattttctcacataaacttatactcgcttaatctcaattgacaagcatctacca aaatactaggtgtttctaggttaagcacacataagatatttacttcaatactcatgtaaa agatccacaacaaaatggtaataagcatttatgtaatttgtctcatgaattgggtatact ctcgtttctattaacacttttttcatagaaatggattttttaatttataaaaaaggattt aaatctatttactatgcagtgttgtgtatctacagtgcattcttaagttccattcactat aggtacaagtggtagcatattcattgtgcctgtcttgcatgaaagcatttactgaagaaa tatgacaagaacatgttcagctaatgaggtcgaatggttgttacattaaatttaggcggt gttttctattaggttttatttatctgtatttgcattcaatcctttcacatttgttatctc tcgcccaattccagggatggggcgccttttctcatttcacagccaattgttactgtgcgc tgactctgtaagttgctggtgaatgtaaaagtgactgcaattaacctgactttgttgctt gaggagaatttgagatgagaaatctgacagcaaatgacaggcatttttctgggtttagca cagaagaaagtctaagtaacattgcaaagagaggcattagggagtaggtacctgcaaatt aagtggctgacactgtctattgagaatttagatagtaacggctggaatttttatgttaag ttcacattattttatattcatagcaagcttccttttgagcatttcctttgtgactgtgca tgatctcatttattgtaatttgtattttttggttgatcagaagatggctgtaattgtaat ttttattaaagcacattcttaacatgtaagaatgcatatatttagatgaaaacaatttta tttttgagaatggattatgtgaacttagattttaatatgataacagcctacccctaattc tcagagatataatgtgaaatggtggaaaactttgagcaataatactcatggcaggtgagt attttttttaaataatacagttcaatatcagtatacttatcttgtcatttatttctgttg aactgaaggaaagaagtctgactgtacagtcataattctgtcttgcattaactggctagc tatgcttttagcaatagttatttttactttccaaagcctgttggttatgtagtttgaatt acaatctttgccttcaaaagcacactctatacaactacctcctgctagtagatagtaccc acacagtatgcaacatttattgtatttgtcaggtgtttaagaggccattgggagttttaa ttaatgtcagttaggaagatacattgttcagttggaagcagcttgccaagttcttcattt tcctataatccatatagtctactgtctttagggaaatatgcaaaattaaaagttacactg catgctgttgtctttacaacattcagctcatcaagcaaaactctcatgcaaattttaatt tgcccttgagcataatttagaaaccataatcattgaggttttacacagcacagataggaa aaggagattggattaatttacactctcttattcaaatgacctcattacttttatggtaca aactaaggttttgcagctgactgtataggtaaagtactgttaagggtttaaaaagtaata attttctagaatttatctttaaattacattttttaatatttggttaaagacatttctttg gagatctttaaatatcctaaagtttatgtattgatttagaaatgggaaaatgtggcatct atttacatttatcaagtttaactattaggtcttggggccttctatttacttgaaggatct tttcatgaattctgtttcagagttaactttttactgttttcagtaatccctaaagaagtg tacacttggcctgacatatagagttgtcgtctaccacatgatgacactaaagatatatga tatgactgacagtgtagttgatgtgcgttgtcttccctagacaaaacagatggtattgtt ctattatcatccacagttattttaatgtactgtgtccatctgtgttaagatatattacat ggtttcatggaatttacagttcactcctgcagtaactcgatttcactgtttggtctctag agagtttgcaaaatgtcaagctgtagcttgaaaaagaaaagtgaaatctactggaaacta atacttatgaccatttcatgcctgatctgctttgtggtgttgtttagaagctagggtgac gtttataatacaacaggtaaaagaaaagattgtttaatgcatatgaaaaattgtaactgc tcttatTGAGCATTTGTGTCCTAGTCCAPrimer
|
For commercial licensing of the VISTA Enhancer Browser and its associated data please contact Virginia de la Puente (vtdelapuente@lbl.gov) at the Berkeley Lab's Innovation and Partnerships Office.